Second Affiliated Hospital, Zhejiang University, School Of Medicine
Clinical trials sponsored by Second Affiliated Hospital, Zhejiang University, School Of Medicine, explained in plain language.
-
Spirulina's secret protein may shield the liver during surgery
Disease control Recruiting nowThis trial tests whether phycocyanin, a natural protein from spirulina, can reduce liver injury and support recovery in adults having part of their liver removed due to intrahepatic cholangiocarcinoma. About 30 participants will take either phycocyanin or a placebo daily for thre…
Phase: NA • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a tailored diet before surgery boost liver cancer recovery?
Disease control Recruiting nowThis trial tests whether a personalized nutrition plan, combined with exercise and psychological support before surgery, can improve outcomes for people with primary liver cancer. Participants are randomly assigned to receive either standard dietary advice or an enhanced program …
Phase: NA • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New heart valve procedure could offer safer alternative to Open-Heart surgery for seniors
Disease control Recruiting nowThis study tests whether a newer, less invasive procedure called transcatheter aortic valve replacement (TAVR) using the J-VALVE device is as safe and effective as traditional open-heart surgery for people with severe aortic regurgitation (a leaky heart valve). About 1,250 adults…
Phase: NA • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could an allergy pill mend hearts after an attack?
Disease control Recruiting nowThis trial tests whether fexofenadine, a common allergy medication, can help the heart heal better after a severe type of heart attack called STEMI. Participants will receive either fexofenadine or a placebo for six months, alongside standard care, after undergoing a procedure to…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Allergy pill tested to protect heart attack survivors
Disease control Recruiting nowThis study is testing whether fexofenadine, a common allergy medication, can reduce the risk of serious heart and brain events in people who have recently had a heart attack. About 2,800 participants will receive either fexofenadine or a placebo for 24 months. The goal is to see …
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a Two-Drug attack reach cancer hiding in the brain?
Disease control Recruiting nowThis trial is testing whether combining two drugs—amivantamab given intravenously and pemetrexed injected directly into the spinal fluid—can safely help people with a specific type of lung cancer that has spread to the membranes around the brain and spinal cord. This condition, c…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a One-Two punch fix a leaky heart valve and restore normal rhythm?
Disease control Recruiting nowThis trial tests whether combining a minimally invasive heart valve repair (TEER) with an electrical shock to restore normal heart rhythm (cardioversion) can improve outcomes for people with severe mitral regurgitation and atrial fibrillation. Participants who have already had a …
Phase: NA • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Blood test could replace needle biopsies for breast cancer staging
Diagnosis Recruiting nowThis study is testing a new blood test called TuFEst that uses DNA fragments and deep learning to stage breast cancer and check if it has spread to lymph nodes. Researchers will enroll 269 breast cancer patients, including those having surgery and those receiving chemotherapy bef…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Could a magnet zap away PTSD?
Symptom relief Recruiting nowThis study tests whether a type of magnetic brain stimulation called iTBS can help people with PTSD. Researchers will give 140 adults either real or fake (sham) stimulation to see if it reduces symptoms like flashbacks and anxiety. The goal is to find a new, non-drug treatment op…
Phase: NA • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Simple CT scan may replace invasive heart tests for millions
Knowledge-focused Recruiting nowThis study looks at whether a special CT scan (CT-FFR) can help doctors predict heart attacks and other serious events in people with chronic coronary syndrome. About 3,000 participants in China will be followed for up to 5 years. The goal is to see if abnormal CT-FFR results are…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can a new sedative make anesthesia safer for seniors?
Knowledge-focused Recruiting nowThis study looks at two sedative drugs, remimazolam and midazolam, used to put older adults (65+) to sleep for non-cardiac surgery. The goal is to see which one offers better heart and blood pressure stability, faster recovery, and fewer complications like confusion after surgery…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC